Sunitinib in patients with metastatic non-clear renal cell carcinoma: A multicentric retpospective Turkish Oncology Group (TOG) trial.
dc.contributor.author | Yildiz, Ibrahim | |
dc.contributor.author | Ekenel, Meltem | |
dc.contributor.author | Altman, Tuley | |
dc.contributor.author | Kocar, Muharrem | |
dc.contributor.author | Uysal, Mukremin | |
dc.contributor.author | Kanitez, Metin | |
dc.contributor.author | Bayoglu, Vedat | |
dc.date.accessioned | 2024-04-24T17:14:58Z | |
dc.date.available | 2024-04-24T17:14:58Z | |
dc.date.issued | 2014 | |
dc.department | Dicle Üniversitesi | en_US |
dc.description | 50th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) -- MAY 30-JUN 03, 2014 -- Chicago, IL | en_US |
dc.description.abstract | [Abstract Not Available] | en_US |
dc.description.sponsorship | Amer Soc Clin Oncol | en_US |
dc.identifier.doi | 10.1200/jco.2014.32.15_suppl.e15602 | |
dc.identifier.issn | 0732-183X | |
dc.identifier.issn | 1527-7755 | |
dc.identifier.issue | 15 | en_US |
dc.identifier.uri | https://doi.org/10.1200/jco.2014.32.15_suppl.e15602 | |
dc.identifier.uri | https://hdl.handle.net/11468/18283 | |
dc.identifier.volume | 32 | en_US |
dc.identifier.wos | WOS:000358613200740 | |
dc.identifier.wosquality | Q1 | |
dc.indekslendigikaynak | Web of Science | |
dc.language.iso | en | en_US |
dc.publisher | Lippincott Williams & Wilkins | en_US |
dc.relation.ispartof | Journal of Clinical Oncology | |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | [No Keyword] | en_US |
dc.title | Sunitinib in patients with metastatic non-clear renal cell carcinoma: A multicentric retpospective Turkish Oncology Group (TOG) trial. | en_US |
dc.title | Sunitinib in patients with metastatic non-clear renal cell carcinoma: A multicentric retpospective Turkish Oncology Group (TOG) trial. | |
dc.type | Conference Object | en_US |